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Poster Session I S227earlier years were more prevalent in non-responders. With adjust-
ments for age and gender recommendations where appropriate, me-
dian adherence to recommended guidelines was 75%. (Table) An
ordinal regression analysis showed that lower adherence was signif-
icantly associated with autologous HCT, concerns about medical
costs, non-White race, male gender, and self-reported lack of knowl-
edge about recommended screening tests, all p\0.01.While 98% of
respondents had medical insurance, 24% reported one or more ac-
tions to limit medical costs: decreasing the dose of prescribed med-
ication, not filling a prescription, not making medical appointments,
not using health services such as physical therapy, or not having a rec-
ommended medical test performed. 3% reported filing for bank-
ruptcy due to medical expenses. Multivariate modeling showed
that concern about costs was associated with female gender, age
younger than 65 years, and low physical and mental functional status
as measured by the SF-12, all p\ 0.01.
Conclusion: Although self-reported adherence to screening prac-
tices overall was high among respondents, selected practices
had\50% adherence, and lower adherence overall was associated
with type of HCT, race, gender, and self-reported financial concerns
and lack of knowledge. 24% of respondents reported that costs influ-
enced their use of medical care. Future work attempting to increase
adherence to recommended preventive care should specifically target
selected practices associated with lower adherence and must recog-
nize that financial concerns may be a significant barrier for some pa-
tients.
Table. Use of preventive care
Asymptomatic
Preventive
care
Target Population
and Frequency N eligible AdherenceBlood
pressure
testAll, every clinic visit,
at least every 2
years1849 95% within
2 yearsDental
examAll, annually 1849 91% within
2 yearsCholesterol test Women older
than 45 and
men older
than 35,
every 5 years153689% within
5 years
Breast examination Women 20-40
every 3
years;
women over
40, annually86992% within
2 yearsMammogram Women over
40, annually 72489% within
2 yearsGynecologic
examWomen greater
than 21,
annually or at
least every 3
years86987% within
2 years
Pap smear Women greater
than 21, annually
or at least every
3 years869 85% within
2 yearsColonoscopy or
sigmoidoscopyAll greater than
50 years,
every 5 years
forsigmoidoscopy
or 10 years for
colonoscopy1222 77% within
5 years(Continued )Table. (Continued )Preventive
careAsymptomatic
Target Population
and Frequency N eligible AdherenceStool occult
blood
testAll greater than 50
years, annually1222 44% within
2 yearsSkin exam
by
medical
providerAll, annually 1849 62% within
2 yearsSkin exam
by
patient
or familyAll, annually 1849 65% within
2 yearsThyroid
blood
testAll, annually 1849 47% within
2 years186
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The objective of this study is to analyze the long term neurocog-
nitive (NC) effects in infants diagnosed with ALL at age less than 12
months and treated with allogeneic HSCT and TBI. Retrospective
review of medical records of eligible patients transplanted from
1992 through 2004 at a single institution was performed. Twenty pa-
tients were identified and we now report on 13 who havemore than 5
year follow-up. Among these 13 patients, 69%were male, 46%Cau-
casian, 38%Hispanic, 15% African American. 38% had central ner-
vous system involvement at diagnosis. 23% had +MLL gene
rearrangement and 8% had t (4:11). The conditioning regimen in-
cluded TBI 1200 cGy (fractions of 150  8), cyclophosphamide
60 mg/Kg daily 3 days and etoposide 1000 mg/m2 single dose (cy-
tarabine was substituted for etoposide in 1 patient). Stem cell sources
are as follows: 54%matched related donor, 8% related matched um-
bilical cord blood (UCB),and 38% unrelatedUCB.Graft versus host
disease (GvHD) prophylaxis were cyclosporine (CsA) alone (n5 3,
23%), CsA+methotrexate (MTX) (n5 7, 54%) or CsA+anti-thymo-
cyte gobulin +MTX. (n5 3, 23%). Leukemia free survival was 85%
at 5 years. Lansky functional scores were100% (n5 7), 90% (n5 2),
70% (n5 1), data in 1 patient not available. NC data was available in
10 patients. Two received formal NC evaluation via Child Psychia-
try, 7 have school individualized educational plans (IEP). Four with
an IEP are inmainstreamed classes while 3 require self-contained/as-
sisted classrooms. Two have no current IEP. 90%have age appropri-
ate social skills; 90% are in organized sports/extra-curricular
activities. 20% are currently in high school, the remainder in ele-
mentary school and advancing. TBI is generally avoided in this pa-
tient population to minimize late effects, and while all patients in
this cohort have some measurable degree of NC effect, their overall
level of function allows for healthy school, family, social, and sport
participation.187
PATIENT CHARACTERISTICS, QUALITY OF LIFE, MOOD STATES, AND
COPING OF OVER 60 COMPARED TO UNDER 60 YEAR OLD AUTOLOGOUS
STEM CELL PATIENTS PRE- AND POST- TRANSPLANT
McLellan, L.1, Dabney, J.1, Rybicki, L.1, Foster, L.W.2, Visnosky, M.1,
Curtis, J.1, Bolwell, B.1 1Cleveland Clinic, OH; 2Cleveland State Univer-
sity, OH
This analysis looks at the differences in experience of transplant of
patients 60+ and under 60 years of age undergoing autologous stem
cell transplantation (ASCT). We reviewed 304 adult patients who
underwent ASCT between June 2003 and December 2007, and
